The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Streptozotocin-induced sporadic Alzheimer’s disease: Selection of appropriate dose
Abstract
The long term effect of single (day 1) and twice (day 1 and 3) injections of intracerebroventricular (ICV) streptozotocin (STZ) at the doses of 1 and 3 mg/kg on the cognitive functions of male Wistar rats was evaluated. Elevated plus maze, passive avoidance, and Morris water maze tests were used to assess the cognitive functions. A significant cognitive deficit was found at the 2nd week onwards, which persisted up to the 14th week with single and twice ICV-STZ (3 mg/kg) injections, whereas no cognitive impairment was found in ICV-STZ (1 mg/kg) treated groups after 8-10 weeks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mehla and colleagues showed anti-AD effects of C. ternatea in ICV-STZ induced AD-like conditions in rats [145].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [145]
In the citing paper
“Pretreatment with hydro-alcoholic extract at the doses of 100, 300 and 500 mg/kg, p.o ameliorated the ICV-STZ induced cognitive impairment by decreasing the oxidative stress and rho kinase (ROCK II) expression in the rat brain [15,145].”
From Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment (2020) · cites this paper as [145]
Citations
Cites
Developments of a water-maze procedure for studying spatial learning in the rat
Morris, R. (1984) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(84)90007-4 · Cited by 7,180
Lannert, H., & Hoyer, S. (1998) · Behavioral Neuroscience · doi:10.1037/0735-7044.112.5.1199 · Cited by 525
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Hong, M., & Lee, V. M. ‐. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 522
Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation
Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488
Grünblatt, E., Šalković‐Petrišić, M., Barilar, J. O., Riederer, P. F., & Hoyer, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04368.x · Cited by 376
Apolipoprotein E Polymorphism and Alzheimer Disease
Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandav, R. S., Belle, S. H., & DeKosky, S. T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.824 · Cited by 338
Sharma, M., & Gupta, Y. K. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)01005-5 · Cited by 260
Self-citationSalkovic-Petrisic, M., & Hoyer, S. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_28 · Cited by 252
Veerendra Kumar, M., & Gupta, Y. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03842.x · Cited by 249
Self-citationDeng, Y., Li, B., Liu, Y. M., Iqbal, K., Grundke, I., & Gong, C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090157 · Cited by 233
Cited by
Sorted by citations
Items 101–114 of 114
Tiwari, V., Singh, J., Tiwari, P., Chaturvedi, S., Gupta, S., Mishra, A., Singh, S., Wahajuddin, M., Hanif, K., & Shukla, S. (2021) · Research Square · doi:10.21203/rs.3.rs-1002782/v1 · Cited by 1
Astrocytes: Puzzle in Neurodegeneration
Singh, S. (2015) · Research and reviews : journal of pharmaceutics and nanotechnology
Esteves, I. D. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-26082016-110343
Morbus Alzheimer: Polyätiologie und multifaktorielle Schrittmacher
Mosetter, K. (2017) · Erfahrungsheilkunde · doi:10.1055/s-0043-103000
Status of Neuropharmacology Research in India
Gupta, Y. K., Katyal, J., & Gupta, S. (2018) · Revista de Fomento Social · doi:10.16943/ptinsa/2018/49309
Self-citationDyke, K. V., Geldenhuys, W. J., & Robart, A. R. (2017) · International Journal of open Access Ophthalmology · doi:10.15226/2474-9249/2/2/00121
Terapia celular y génica con timulina E IGF-1 en modelos animales de neuroinflamación
Villar, M. F. Z. (2018) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/71572
Patil, H., Pardeshi, C., Khule, S. P., & Gagarani, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3334133/v1
Huang, H.-J., Chen, J.-L., Liao, J.-F., Chen, Y.-H., Chieu, M.-W., Ke, Y.-Y., Hsu, C.-C., Tsai, Y.-C., & Hsieh-Li, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.16779829
Gong, P., Chen, Y.-Q., Lin, A.-H., Zhang, H.-B., Zhang, Y., Ye, R. D., & Yu, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13233231
Salari, M. T., Gholami, K., Khani, L., Ahmadnia, H., Iranshahy, M., Iranshahi, M., Majd, M. T., Behnam-Rassouli, M., Yazarlu, O., & Hasanpour, M. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-026-01118-y
Zakaria, M. K., Hazalin, N. A. M. N., Chellammal, H. S. J., & Singh, G. K. S. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-01943-y
STZ‑induced sporadic Alzheimer’s in rats: behavioral, histopathological, and MiRNA profiles
Moustafa, N., Gaballa, Z., Haiba, S., & Abdellatif, A. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10979-w
Metadata
- Authors
- Mehla, J., Pahuja, M., & Gupta, Y. K.
- Affiliations
- All India Institute of Medical Sciences (IN)
- Corresponding author
- Gupta, Yogendra Kumar
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2012-12-03
- Volume
- 33
- Issue
- 1
- Pages
- 17-21
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1670803694
- Cited by
- 113
- References
- 25
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 6 · 2018: 14 · 2017: 11 · 2016: 3 · 2015: 4 · 2014: 2 · 2013: 1
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- streptozotocin, Alzheimer's disease model
- MeSH terms
- Alzheimer Disease, Animals, Avoidance Learning, Disease Models, Animal, Injections, Intraventricular, Male, Streptozocin, Rats, Wistar, Maze Learning, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
